Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Molecular classification improves risk assessment in adult BCR-ABL1– negative B-ALL

Blood (2021) 138 (11): 948–958.

https://doi.org/10.1182/blood.2020010144

Published: 2021

Includes: Supplemental data

Journal Articles

Treatment-influenced associations of PML-RAR α mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Blood (2012) 120 (10): 2098–2108.

https://doi.org/10.1182/blood-2012-01-407601

Published: 2012

Includes: Supplemental data

Journal Articles

Lack of Somatic Sequence Mutations In Protein Tyrosine Kinase Genes Other Than the JAK Kinase Family In High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project

Jinghui Zhang, Ph.D., Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Richard Harvey, PhD, William L. Carroll, MD, I-Ming L. Chen, DVM, MS, Meenakshi Devidas, PhD, Eric Larsen, Michael Edmonson, Ph.D., Ken Buetow, Ph.D., Daniela S Gerhard, Ph.D., Mignon L. Loh, M.D., Gregory H. Reaman, MD, Mary V. Relling, PharmD, Malcolm A Smith, M.D., Ph.D., James R. Downing, MD, Cheryl L. Willman, MD, Stephen Hunger, MD

Blood (2010) 116 (21): 2752.

https://doi.org/10.1182/blood.V116.21.2752.2752

Published: 2010

Journal Articles

Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL - ENL , and gene Expression Profiles Determine Obatoclax IC 50 : A Report on the Children's Oncology Group (COG) P9407 Trial

Blood (2010) 116 (21): 2757.

https://doi.org/10.1182/blood.V116.21.2757.2757

Published: 2010

Journal Articles

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.

Blood (2010) 116 (21): 1038.

https://doi.org/10.1182/blood.V116.21.1038.1038

Published: 2010

Journal Articles

Select γ-Secretase Inhibitors Induce Apoptosis in Pre-B ALL Cells and Disrupt the Balance Between Constitutive Notch Signaling and Repression.

Bridget S. Wilson, PhD, Xiangbing Meng, MD, Tomas Mazel, MD/PhD, Cheryl L. Willman, MD, Susan Atlas, PhD, Richard Harvey, PhD, I-Ming Chen, MD, Stephen P. Hunger, MD, Janet M Oliver, PhD, Stuart S. Winter, MD

Blood (2008) 112 (11): 1917.

https://doi.org/10.1182/blood.V112.11.1917.1917

Published: 2008

Journal Articles

Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group.

Julie M. Gastier-Foster, PhD, Andrew J. Carroll, PhD, Denise Ell, BS, Richard Harvey, PhD, I-Ming Chen, PhD, Rhett Ketterling, MD, Aurelia Meloni-Ehrig, PhD, Kent E. Opheim, PhD, Shivanand Patil, PhD, Mark Pettenati, PhD, Kathleen Rao, PhD, ShiQi Wu, PhD, Nyla A. Heerema, PhD

Blood (2007) 110 (11): 1439.

https://doi.org/10.1182/blood.V110.11.1439.1439

Published: 2007

Journal Articles

Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.

Michael J. Borowitz, MD, PhD, Meenakshi Devidas, PhD, W. Paul Bowman, MD, William L. Carroll, MD, I.-Ming Chen, MD, Richard Harvey, PhD, Stephen Hunger, MD, Paul L. Martin, Jeanette Pullen, MD, David Viswanatha, MD, Cheryl L. Willman, MD, Naomi Winick, MD, Bruce Camitta, MD

Blood (2006) 108 (11): 219.

https://doi.org/10.1182/blood.V108.11.219.219

Published: 2006

Journal Articles

Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.

Wendy Stock, MD, Richard Harvey, MD, Barry Moser, PhD, Dorie Sher, BS, Esther Schachter-Tokarz, BS, Matthew Myers, BS, James Slack, MD, Bayard Powell, MD, Clara D. Bloomfield, MD, Richard A. Larson, MD, Martin S. Tallman, MD, Frederick R. Appelbaum, MD, James Feusner, MD, Cheryl Willman, MD, Robert Gallagher, MD

Blood (2006) 108 (11): 494.

https://doi.org/10.1182/blood.V108.11.494.494

Published: 2006

Journal Articles

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction

Blood (2006) 108 (2): 685–696.

https://doi.org/10.1182/blood-2004-12-4633

Published: 2006

Includes: Supplemental data

Journal Articles

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Naomi P. Moskowitz, MD, Deepa Bhojwani, MD, Huining Kang, PhD, Dong-Joon Min, PhD, Jeffrey Potter, PhD, Richard Harvey, PhD, Nita L. Seibel, MD, Elizabeth Raetz, MD, Harland N. Sather, PhD, Stephen P. Hunger, MD, Cheryl L. Willman, MD, William L. Carroll, MD

Blood (2005) 106 (11): 1449.

https://doi.org/10.1182/blood.V106.11.1449.1449

Published: 2005

NARROW

Molecular classification improves risk assessment in adult BCR-ABL1– negative B-ALL

Treatment-influenced associations of PML-RAR α mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia

Lack of Somatic Sequence Mutations In Protein Tyrosine Kinase Genes Other Than the JAK Kinase Family In High Risk B-Precursor Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project

Infant Acute Lymphoblastic Leukemias Are Pan-Sensitive to Obatoclax Across molecular/Cytogenetic Subtypes, Especially MLL - ENL , and gene Expression Profiles Determine Obatoclax IC 50 : A Report on the Children's Oncology Group (COG) P9407 Trial

Clonal Markers In Relapsed Acute Promyelocytic Leukemia (APL): Clinicopathological Associations and Relation to All-Trans Retinoic Acid (ATRA) Treatment on Intergroup Phase III Trial C9710.

Select γ-Secretase Inhibitors Induce Apoptosis in Pre-B ALL Cells and Disrupt the Balance Between Constitutive Notch Signaling and Repression.

Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group.

Prognostic Significance of Minimal Residual Disease (MRD) in Childhood B-Precursor ALL and Its Relation to Other Risk Factors. A Children’s Oncology Group (COG) Study.

Minimal Residual Disease (MRD) and Risk of Relapse in Acute Promyelocytic Leukemia (APL): Insights from the North American Intergroup Phase III Trial C9710.

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction

Gene Signatures Predictive of Outcome in Higher Risk Childhood Acute Lymphoblastic Leukemia (ALL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only